Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • LP-191 Baseline profile of sys...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort

LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort

Bibliographic Details
Main Authors: Íñigo Rúa-Figueroa, Jose Maria Pego-Reigosa, José A Gómez-Puerta, Javier Narváez, Ivette Casafont-Solé, José Andrés Román-Ivorra, Raúl Menor-Almagro, Jaime Calvo-Alén, Eva Tomero, Julia Martínez-Barrio, María Galindo-Izquierdo, Clara Moriano, Josefina Cortés-Hernández, María Jesús García-Villanueva, Elvira Díez-Álvarez, Irene Altabás-González, Coral Mouriño-Rodriguez, Norman Jiménez-Otero, Andrea Hernández-Martín, Judit Font-Urgelles, Marta De La Rubia-Navarro, Tarek Salman-Montes, Paola Vidal-Montal, Sandra Garrote-Corral, María Ángeles Blázquez-Cañamero, Carlos Marras-Fernández, María Piqueras-García, Marina Sánchez-Lucas, Eleonora Penzo, Juan Ramón De Dios Jiménez De Aberásturi, Belén Álvarez-Rodríguez, Margarida Vasques-Rocha, Myriam Gandía-Martínez, Consuelo Ramos-Giráldez, Carmen Trapero-Pérez, Alejandro Muñoz-Jiménez
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:Lupus Science and Medicine
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort
    by: Íñigo Rúa-Figueroa, et al.
    Published: (2024-03-01)
  • P147 Is belimumab dose optimization possible in patients with systemic lupus erythematosus? Analysis of this therapeutic strategy in a large multicenter cohort of patients from Spanish rheumatology departments
    by: Íñigo Rúa-Figueroa, et al.
    Published: (2024-03-01)
  • P129 Does the perspective of SLE patients match the expert opinion and definitions of remission and low disease activity state? Prospective analysis of 500 patients from a Spanish multicenter cohort
    by: María Galindo, et al.
    Published: (2024-03-01)
  • P149 Clinical worsening in non-adherent belimumab treatment in SLE
    by: José Ivorra Cortés, et al.
    Published: (2024-03-01)
  • PO.7.157 Does remission according DORIS 2021 match the treating rheumatologist judgement? Analylis at recruitment of a prospective study of 500 SLE patients from a Spanish multicenter cohort
    by: I Rua-Figueroa, et al.
    Published: (2022-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs